Biological age acceleration and the dynamic progression of cardiovascular-kidney-metabolic diseases to multimorbidity, dementia and mortality: A prospective cohort study
This prospective cohort study of over 433,000 UK Biobank participants demonstrates that biological age acceleration significantly increases the risk of transitioning from health to cardiovascular-kidney-metabolic disease, accelerates progression to multimorbidity and dementia, and reduces life expectancy, highlighting its potential as a critical biomarker for early intervention.